B.C. woman with rare autoimmune condition shares expertise in reimagined chapter of Winnie-the-Pooh

Myasthenia gravis affects about 30 out of every 100,000 people in Canada, according to the Myasthenia Gravis Society of ...

Amitabh Bachchan's health battles: From the near-fatal Coolie accident in 1982 to living with a 75% damaged liver, Myasthenia Gravis and more

Amitabh Bachchan recently revealed that he underwent surgery and described his recovery after being discharged from the ...

Connecticut hospitals missed diagnosis that led to Cheshire father's death, lawsuit says

The estate of a Cheshire man is suing several Connecticut healthcare providers, contending doctors failed to diagnose the ...

A man’s family says he was misdiagnosed at CT hospitals. He died just weeks later.

The estate of a Connecticut man is suing three Connecticut hospitals and others in his alleged wrongful death after what they ...

Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized ...

Johnson & Johnson (NYSE: JNJ) today announced new data across 12 abstracts at the European Academy of Neurology (EAN) 2026 Congress that offer additional insight into the use of IMAAVY® ...
The Manila Times

Johnson & Johnson presents new IMAAVY® (nipocalimab) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalised myasthenia ...

New analyses from the Phase 3 Vivacity-MG3 study support the impact of nipocalimab in anti-AChR+a, anti-MuSK+b adult patients with generalised myasthenia gravis (gMG) including those early in their ...

UCB data reinforce long-term promise for weak muscles disorder

UCB S.A. UCBJY UCBJF on Wednesday presented new data at the International Congress on Neuromuscular Diseases 2026 showing that long-term treatment with rozanolixizumab and zilucoplan delivered ...

Not drinking enough water at work? Neurologist reveals how it affects your brain, shares 7 signs of dehydration

From brain fog to headaches: Learn from an expert on how dehydration can cost your health and productivity at work.

Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)

Cemdisiran could be the first siRNA approved for the treatment of gMG and only therapy to be offered subcutaneously with four times a year dosing FDA accepted NDA under Priority Review with a target ...

Regeneron (REGN) Secures FDA Priority Review And EMA Acceptance For Cemdisiran

Regeneron Pharmaceuticals (NasdaqGS:REGN) received FDA acceptance with Priority Review for cemdisiran in generalized myasthenia gravis. The EMA has also accepted the marketing application for ...